# Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics

> **NCT00262652** · PHASE1,PHASE2 · TERMINATED · sponsor: **Emphycorp** · enrollment: 20 (actual)

## Conditions studied

- Moderate Asthma

## Interventions

- **DRUG:** sodium pyruvate

## Key facts

- **NCT ID:** NCT00262652
- **Lead sponsor:** Emphycorp
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-01
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** Patients did not respond to therapy
- **Last updated:** 2011-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00262652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00262652, "Safety and Efficacy Study of the Use of Sodium Pyruvate Bronchodilation in Asthmatics". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00262652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*